Cargando…
Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546420/ https://www.ncbi.nlm.nih.gov/pubmed/26295457 http://dx.doi.org/10.1371/journal.pone.0136507 |
_version_ | 1782386925203619840 |
---|---|
author | Gong, Zhen Martin-Garcia, Jose M. Daskalova, Sasha M. Craciunescu, Felicia M. Song, Lusheng Dörner, Katerina Hansen, Debra T. Yang, Jay-How LaBaer, Joshua Hogue, Brenda G. Mor, Tsafrir S. Fromme, Petra |
author_facet | Gong, Zhen Martin-Garcia, Jose M. Daskalova, Sasha M. Craciunescu, Felicia M. Song, Lusheng Dörner, Katerina Hansen, Debra T. Yang, Jay-How LaBaer, Joshua Hogue, Brenda G. Mor, Tsafrir S. Fromme, Petra |
author_sort | Gong, Zhen |
collection | PubMed |
description | The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662–683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649–705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM). Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41. |
format | Online Article Text |
id | pubmed-4546420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45464202015-09-01 Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion Gong, Zhen Martin-Garcia, Jose M. Daskalova, Sasha M. Craciunescu, Felicia M. Song, Lusheng Dörner, Katerina Hansen, Debra T. Yang, Jay-How LaBaer, Joshua Hogue, Brenda G. Mor, Tsafrir S. Fromme, Petra PLoS One Research Article The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662–683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649–705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM). Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41. Public Library of Science 2015-08-21 /pmc/articles/PMC4546420/ /pubmed/26295457 http://dx.doi.org/10.1371/journal.pone.0136507 Text en © 2015 Gong et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gong, Zhen Martin-Garcia, Jose M. Daskalova, Sasha M. Craciunescu, Felicia M. Song, Lusheng Dörner, Katerina Hansen, Debra T. Yang, Jay-How LaBaer, Joshua Hogue, Brenda G. Mor, Tsafrir S. Fromme, Petra Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion |
title | Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion |
title_full | Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion |
title_fullStr | Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion |
title_full_unstemmed | Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion |
title_short | Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion |
title_sort | biophysical characterization of a vaccine candidate against hiv-1: the transmembrane and membrane proximal domains of hiv-1 gp41 as a maltose binding protein fusion |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546420/ https://www.ncbi.nlm.nih.gov/pubmed/26295457 http://dx.doi.org/10.1371/journal.pone.0136507 |
work_keys_str_mv | AT gongzhen biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT martingarciajosem biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT daskalovasasham biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT craciunescufeliciam biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT songlusheng biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT dornerkaterina biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT hansendebrat biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT yangjayhow biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT labaerjoshua biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT hoguebrendag biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT mortsafrirs biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion AT frommepetra biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion |